Cargando…
Multivariate analysis of PET pharmacokinetic parameters improves inferential efficiency
PURPOSE: In positron emission tomography quantification, multiple pharmacokinetic parameters are typically estimated from each time activity curve. Conventionally all but the parameter of interest are discarded before performing subsequent statistical analysis. However, we assert that these discarde...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008760/ https://www.ncbi.nlm.nih.gov/pubmed/36907944 http://dx.doi.org/10.1186/s40658-023-00537-8 |
_version_ | 1784905828724113408 |
---|---|
author | Matheson, Granville J. Ogden, R. Todd |
author_facet | Matheson, Granville J. Ogden, R. Todd |
author_sort | Matheson, Granville J. |
collection | PubMed |
description | PURPOSE: In positron emission tomography quantification, multiple pharmacokinetic parameters are typically estimated from each time activity curve. Conventionally all but the parameter of interest are discarded before performing subsequent statistical analysis. However, we assert that these discarded parameters also contain relevant information which can be exploited to improve the precision and power of statistical analyses on the parameter of interest. Properly taking this into account can thereby draw more informative conclusions without collecting more data. METHODS: By applying a hierarchical multifactor multivariate Bayesian approach, all estimated parameters from all regions can be analysed at once. We refer to this method as Parameters undergoing Multivariate Bayesian Analysis (PuMBA). We simulated patient–control studies with different radioligands, varying sample sizes and measurement error to explore its performance, comparing the precision, statistical power, false positive rate and bias of estimated group differences relative to univariate analysis methods. RESULTS: We show that PuMBA improves the statistical power for all examined applications relative to univariate methods without increasing the false positive rate. PuMBA improves the precision of effect size estimation, and reduces the variation of these estimates between simulated samples. Furthermore, we show that PuMBA yields performance improvements even in the presence of substantial measurement error. Remarkably, owing to its ability to leverage information shared between pharmacokinetic parameters, PuMBA even shows greater power than conventional univariate analysis of the true binding values from which the parameters were simulated. Across all applications, PuMBA exhibited a small degree of bias in the estimated outcomes; however, this was small relative to the variation in estimated outcomes between simulated datasets. CONCLUSION: PuMBA improves the precision and power of statistical analysis of PET data without requiring the collection of additional measurements. This makes it possible to study new research questions in both new and previously collected data. PuMBA therefore holds great promise for the field of PET imaging. |
format | Online Article Text |
id | pubmed-10008760 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-100087602023-03-14 Multivariate analysis of PET pharmacokinetic parameters improves inferential efficiency Matheson, Granville J. Ogden, R. Todd EJNMMI Phys Original Research PURPOSE: In positron emission tomography quantification, multiple pharmacokinetic parameters are typically estimated from each time activity curve. Conventionally all but the parameter of interest are discarded before performing subsequent statistical analysis. However, we assert that these discarded parameters also contain relevant information which can be exploited to improve the precision and power of statistical analyses on the parameter of interest. Properly taking this into account can thereby draw more informative conclusions without collecting more data. METHODS: By applying a hierarchical multifactor multivariate Bayesian approach, all estimated parameters from all regions can be analysed at once. We refer to this method as Parameters undergoing Multivariate Bayesian Analysis (PuMBA). We simulated patient–control studies with different radioligands, varying sample sizes and measurement error to explore its performance, comparing the precision, statistical power, false positive rate and bias of estimated group differences relative to univariate analysis methods. RESULTS: We show that PuMBA improves the statistical power for all examined applications relative to univariate methods without increasing the false positive rate. PuMBA improves the precision of effect size estimation, and reduces the variation of these estimates between simulated samples. Furthermore, we show that PuMBA yields performance improvements even in the presence of substantial measurement error. Remarkably, owing to its ability to leverage information shared between pharmacokinetic parameters, PuMBA even shows greater power than conventional univariate analysis of the true binding values from which the parameters were simulated. Across all applications, PuMBA exhibited a small degree of bias in the estimated outcomes; however, this was small relative to the variation in estimated outcomes between simulated datasets. CONCLUSION: PuMBA improves the precision and power of statistical analysis of PET data without requiring the collection of additional measurements. This makes it possible to study new research questions in both new and previously collected data. PuMBA therefore holds great promise for the field of PET imaging. Springer International Publishing 2023-03-13 /pmc/articles/PMC10008760/ /pubmed/36907944 http://dx.doi.org/10.1186/s40658-023-00537-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Research Matheson, Granville J. Ogden, R. Todd Multivariate analysis of PET pharmacokinetic parameters improves inferential efficiency |
title | Multivariate analysis of PET pharmacokinetic parameters improves inferential efficiency |
title_full | Multivariate analysis of PET pharmacokinetic parameters improves inferential efficiency |
title_fullStr | Multivariate analysis of PET pharmacokinetic parameters improves inferential efficiency |
title_full_unstemmed | Multivariate analysis of PET pharmacokinetic parameters improves inferential efficiency |
title_short | Multivariate analysis of PET pharmacokinetic parameters improves inferential efficiency |
title_sort | multivariate analysis of pet pharmacokinetic parameters improves inferential efficiency |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008760/ https://www.ncbi.nlm.nih.gov/pubmed/36907944 http://dx.doi.org/10.1186/s40658-023-00537-8 |
work_keys_str_mv | AT mathesongranvillej multivariateanalysisofpetpharmacokineticparametersimprovesinferentialefficiency AT ogdenrtodd multivariateanalysisofpetpharmacokineticparametersimprovesinferentialefficiency |